0
Sleep Disorders |

Influence of Alprazolam Premedication on the Occurrence of Postoperative Obstructive Apnea

Eric Deflandre, MD; Anne-Catherine Courtois, MD; Stephanie Degey, MHS; Jean-Francois Brichant, PhD; Pol Hans, PhD; Robert Poirrier, PhD; Vincent Bonhomme, PhD
Author and Funding Information

Cabinet Medical ASTES & Clinique Saint-Luc, Namur, Belgium


Chest. 2014;145(3_MeetingAbstracts):591A. doi:10.1378/chest.1788951
Text Size: A A A
Published online

Abstract

SESSION TITLE: OSA Posters

SESSION TYPE: Poster Presentations

PRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PM

PURPOSE: Obstructive apneas can be a serious perioperative complication. Every anesthesiologist should be aware of the influence of anesthetic medications on the occurrence of such apneas. We studied the effect of an oral premedication with 0.5 mg alprazolam in patients scheduled for day-care colonoscopy.

METHODS: After IRB approval and informed consent, 50 patients (ASA I-II) were included. Patients with an OSA (Obstructive Sleep Apnea) syndrome were excluded. Patients were randomized in two groups: group A received an oral premedication using 0.5 mg alprazolam and group C received a placebo. Anesthesia was performed using ketamine (single iv bolus of 0.5 mg kg-1) and a continuous infusion of propofol targeted to achieve a BIS (BISpectral Index) value between 50 and 60. Patients were on spontaneous respiration. Statistics were performed using the Mann-Whitney’s test and the Fisher’s test. A two-tailed P value lower than 0.05 was considered significant. Data were expressed in mean + standard deviation.

RESULTS: 9 patients were excluded (4 in group A, 5 in group C) because of technical problems with recording or patient's wishes. Groups were comparable in terms of demographic data and amount of propofol administered. The recruited patients were not obese (BMI A: 24.87 + 4.2 and BMI C: 24.02 + 3.13). The AHI (Apnea Hypopnea Index which is defined by the number of apnea and hypopnea per hour) was significantly higher in group A than in Group C (A: 20.33 + 10.97, C: 9.63 + 4.67, P = 0.0003). However, these apneas never induced any significant drop in peripheral saturation in oxygen or any mandibular instability.

CONCLUSIONS: Our study emphasizes that premedication with 0.5 mg of alprazolam causes an increase in obstructive apneas during at least the first two postoperative hours.

CLINICAL IMPLICATIONS: A premedication with 0,5 mg of alprazolam was not harmful in our study population but might be dangerous in patients already predisposed to the occurrence of obstructive apneas (obese patients and/or with OSA Syndrome). Specifically dedicated studies should be designed to address this point.

DISCLOSURE: The following authors have nothing to disclose: Eric Deflandre, Anne-Catherine Courtois, Stephanie Degey, Jean-Francois Brichant, Pol Hans, Robert Poirrier, Vincent Bonhomme

No Product/Research Disclosure Information


Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543